Famotidine recalls
Famotidine products have been recalled 10 times, most recently on 9 Sep 2026. The recalling company is usually Baxter Healthcare. The most common reason is potency & assay.
Total recalls10since 2014
Last 12 months2reported
Class I110% of total
Ongoing2latest 9 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 10%Class II 5 50%Class III 4 40%
Why famotidine is recalled
Companies
Product types
By year
Ongoing famotidine recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Famotidine Injection in Sodium Chloride Injection, 20 mg recalledFamotidine | Baxter Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS I | Famotidine Injection, USP, 20 mg per (10 mg per mL) vials recalledFamotidine | Fresenius Kabi USA | Sterility | Nationwide |
All famotidine recalls, newest first
10 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.